Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.

Summary

The resolution asks the FDA and Congress to base any rules on the extensive safety record of mifepristone and to make access to medication abortion transparent and fair. It targets patients who need the drug, their doctors and pharmacies, and regulators, stressing that the medication is proven safe and effective.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share